Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/181514
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFernandes, Ana Rita-
dc.contributor.authorDos Santos, Tiago-
dc.contributor.authorGranja, Pedro L.-
dc.contributor.authorSánchez-López, E. (Elena)-
dc.contributor.authorSantini, Antonello-
dc.contributor.authorGarcía López, María Luisa-
dc.contributor.authorSilva, Amélia M.-
dc.contributor.authorSouto, Eliana B.-
dc.date.accessioned2021-11-25T13:57:33Z-
dc.date.available2021-11-25T13:57:33Z-
dc.date.issued2021-10-10-
dc.identifier.issn1999-4923-
dc.identifier.urihttp://hdl.handle.net/2445/181514-
dc.description.abstractQuaternary derivatives of 1,4-diazabicyclo[2.2.2]octane (DABCO) and of quinuclidine surfactants were used to develop oil-in-water nanoemulsions with the purpose of selecting the best long-term stable nanoemulsion for the ocular administration of triamcinolone acetonide (TA). The combination of the best physicochemical properties (i.e., mean droplet size, polydispersity index, zeta potential, osmolality, viscoelastic properties, surface tension) was considered, together with the cell viability assays in ARPE-19 and HMC3 cell lines. Surfactants with cationic properties have been used to tailor the nanoemulsions' surface for site-specific delivery of drugs to the ocular structure for the delivery of TA. They are tailored for the eye because they have cationic properties that interact with the anionic surface of the eye. Keywords: cationic nanoemulsions, DABCO surfactants, quinuclidine surfactants, ocular administration, triamcinolone acetonide, age-related macular degeneration, HMC3 cell line, ARPE-19 cell line-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/pharmaceutics13101652-
dc.relation.ispartofPharmaceutics, 2021, vol. 13, num. 1652-
dc.relation.urihttps://doi.org/10.3390/pharmaceutics13101652-
dc.rightscc-by (c) Fernandes, Ana Rita et al., 2021-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)-
dc.subject.classificationEmulsions (Farmàcia)-
dc.subject.classificationNanofluids-
dc.subject.classificationFarmacologia ocular-
dc.subject.classificationNanociència-
dc.subject.otherEmulsions (Pharmacy)-
dc.subject.otherNanofluids-
dc.subject.otherOcular pharmacology-
dc.subject.otherNanoscience-
dc.titleDABCO-Customized Nanoemulsions: Characterization, Cell Viability and Genotoxicity in Retinal Pigmented Epithelium and Microglia Cells-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec714860-
dc.date.updated2021-11-25T13:57:33Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid34683945-
Appears in Collections:Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
714860.pdf2.08 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons